Business Description
Alibaba Health Information Technology Ltd
ISIN : BMG0171K1018
Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 116.26 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 242.58 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 8.61 | |||||
| Beneish M-Score | -2.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.5 | |||||
| 3-Year EBITDA Growth Rate | 24.4 | |||||
| 3-Year EPS without NRI Growth Rate | 44.2 | |||||
| 3-Year FCF Growth Rate | -3.1 | |||||
| 3-Year Book Growth Rate | -8.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 44.52 | |||||
| Future 3-5Y Total Revenue Growth Rate | 11.22 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.9 | |||||
| 9-Day RSI | 41.37 | |||||
| 14-Day RSI | 44.19 | |||||
| 6-1 Month Momentum % | 31.42 | |||||
| 12-1 Month Momentum % | -14.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.69 | |||||
| Quick Ratio | 2.41 | |||||
| Cash Ratio | 1.9 | |||||
| Days Inventory | 29.46 | |||||
| Days Sales Outstanding | 8.47 | |||||
| Days Payable | 59.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.1 | |||||
| Shareholder Yield % | 0.16 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.16 | |||||
| Operating Margin % | 4.27 | |||||
| Net Margin % | 4.26 | |||||
| FCF Margin % | 2.56 | |||||
| ROE % | 7.88 | |||||
| ROA % | 5.83 | |||||
| ROIC % | 17.28 | |||||
| ROC (Joel Greenblatt) % | 1387.36 | |||||
| ROCE % | 8.31 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 45.06 | |||||
| Forward PE Ratio | 27.5 | |||||
| PE Ratio without NRI | 47.88 | |||||
| Shiller PE Ratio | 2448.22 | |||||
| Price-to-Owner-Earnings | 85.11 | |||||
| PS Ratio | 1.9 | |||||
| PB Ratio | 3.9 | |||||
| Price-to-Tangible-Book | 4.04 | |||||
| Price-to-Free-Cash-Flow | 76.6 | |||||
| Price-to-Operating-Cash-Flow | 75.1 | |||||
| EV-to-EBIT | 35.21 | |||||
| EV-to-Forward-EBIT | 25.54 | |||||
| EV-to-EBITDA | 34.46 | |||||
| EV-to-Forward-EBITDA | 24.97 | |||||
| EV-to-Revenue | 1.6 | |||||
| EV-to-Forward-Revenue | 1.44 | |||||
| EV-to-FCF | 64.19 | |||||
| Price-to-Projected-FCF | 2.47 | |||||
| Price-to-Median-PS-Value | 0.07 | |||||
| Price-to-Graham-Number | 3.42 | |||||
| Price-to-Net-Current-Asset-Value | 6.35 | |||||
| Price-to-Net-Cash | 11.11 | |||||
| Earnings Yield (Greenblatt) % | 2.84 | |||||
| FCF Yield % | 1.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alibaba Health Information Technology Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3,615.029 | ||
| EPS (TTM) (€) | 0.01 | ||
| Beta | 1.26 | ||
| Volatility % | 92.62 | ||
| 14-Day RSI | 44.19 | ||
| 14-Day ATR (€) | 0.015132 | ||
| 20-Day SMA (€) | 0.47115 | ||
| 12-1 Month Momentum % | -14.48 | ||
| 52-Week Range (€) | 0.3091 - 0.741 | ||
| Shares Outstanding (Mil) | 16,091.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alibaba Health Information Technology Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alibaba Health Information Technology Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alibaba Health Information Technology Ltd Frequently Asked Questions
What is Alibaba Health Information Technology Ltd(STU:TWY)'s stock price today?
The current price of STU:TWY is €0.44. The 52 week high of STU:TWY is €0.74 and 52 week low is €0.31.
When is next earnings date of Alibaba Health Information Technology Ltd(STU:TWY)?
The next earnings date of Alibaba Health Information Technology Ltd(STU:TWY) is 2024-11-29 Est..
Does Alibaba Health Information Technology Ltd(STU:TWY) pay dividends? If so, how much?
Alibaba Health Information Technology Ltd(STU:TWY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers